Favipiravir: Show cause notice to drug wholesaler

The wholesaler had allegedly purchased 58,000 spurious anti-viral drug Favipiravir (Favimax 400) tablets from one Max Relief Health Care, Uttar Pradesh

219
Medicine Tablets
Picture: Unsolash

Last Updated on June 19, 2021 by The Health Master

BHUBANESWAR: The State Drugs Control Administration issued a show-cause notice to Cuttack-based pharmaceutical wholesaler Medilloyd Medicament Pvt Ltd in connection with the seizure of spurious C-19 drugs.

Deputy Drug Controller-cum-Licensing Authority Mamina Patnaik has asked the pharmaceutical wholesaler to reply within three days, failing which action as per the provisions of the Drugs and Cosmetics Act and Rules will be initiated.

Document
Picture: Pixabay

The wholesaler has been issued show cause notice on three clauses as purchase record of drugs intended for resale / wholesale was not maintained and he failed to provide documents during the inspection. Besides, he had purchased drugs from a fictitious manufacturer, which is violation of section 18 (a)(i) of the Act.

The wholesaler had allegedly purchased 58,000 spurious anti-viral drug Favipiravir (Favimax 400) tablets from one Max Relief Health Care, Uttar Pradesh, out of which he had supplied 40,600 tablets to Mahadev Medicals and Surgicals, Gwalior.

Schedules: All types of Clinical Trials

Schedules: All types of Drugs

Schedules: All types of Cosmetics

Schedules: All types of Medical Devices

Govt to amend Schedule K to exempt Antiseptics from sale license

India should immediately start Drug Brand Name Registry: Experts

To watch various informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner